Genus plc
GENSF
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.87B
Close$
$24.68
12.3% downside
Current Fair Value
12.3% downsideOvervalued by 12.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.87 Billion |
|---|---|
| Enterprise Value | $1.94 Billion |
| Dividend Yield | $0.42 (1.40%) |
| Earnings per Share | $4.25 |
| Beta | 0.9 |
| Outstanding Shares | 66,540,000 |
Return
| Return on Equity | 39.73% |
|---|---|
| Return on Assets | 29.91% |
| Return on Invested Capital | 14.17% |
Valuation & Multiples
| P/E Ratio | 5.31 |
|---|---|
| PEG | 0.4 |
| Price to Sales | 1.41 |
| Price to Book Ratio | 2.56 |
| Enterprise Value to Revenue | 1.46 |
| Enterprise Value to EBIT | 15.17 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Genus plc
3,307 employees
CEO: Jorgen Kokke Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three prima...